New York Doctors of Optometry Expand Scope
New York Doctors of Optometry Expand Scope Read More »
Sometimes, your patient won’t know the name of their medication, but they will almost always know the color of the cap. The first time someone told me they took the “one with the blue cap” 2 times a day, I had no idea what they meant! If I had known that blue caps are often
Name That Cap: An Ocular Drug List Classified by Cap Color Read More »
The FDA has approved Lucentis (Ranibizumab) to treat diabetic macular edema as a monthly injection, making it the first drug approved to treat the condition. The 0.3mg one time dosage that has been approved is estimated to cost roughly $1,170. The newly approved drug has been shown to be quite efficacious in improving vision in
Lucentis FDA Approved to Treat Diabetic Macular Edema Read More »
U.S regulatory advisors have backed Lucentis for approval in treatment of diabetic macular edema. The FDA panel recommended the agency to approve a 0.5mg and 0.3mg dose of Lucentis in the treatment of DME. The FDA should decide sometime in August on the approval of the drug for as a treatment option. If approved, Lucentis
Lucentis Backed by FDA Pannel for Extended Approval Read More »